Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
US Army
Express Scripts
Queensland Health
Chinese Patent Office
Deloitte
Fuji
Colorcon

Generated: December 10, 2018

DrugPatentWatch Database Preview

Hydrochlorothiazide; spironolactone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; spironolactone and what is the scope of hydrochlorothiazide; spironolactone freedom to operate?

Hydrochlorothiazide; spironolactone is the generic ingredient in three branded drugs marketed by Gd Searle Llc, Ascot, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Yaopharma Co Ltd, Ivax Pharms, Lederle, Parke Davis, Upsher Smith, Usl Pharma, and Vangard, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; spironolactone. Five suppliers are listed for this compound.

Summary for hydrochlorothiazide; spironolactone
Pharmacology for hydrochlorothiazide; spironolactone
Synonyms for hydrochlorothiazide; spironolactone
C24H32O4S.C7H8ClN3O4S2
Hydrochlorothiazide / Spironolactone
LS-178649
MP 40 [Pill Imprint]
SCHEMBL930086
Spiridazide
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
Spironolactone-hydrochlorothiazide
Spironothiazid
Uractazide

US Patents and Regulatory Information for hydrochlorothiazide; spironolactone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087553-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Superpharm SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 089137-001 Aug 26, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 089534-001 Jul 2, 1987 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 086026-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
McKinsey
US Army
Boehringer Ingelheim
Fish and Richardson
Moodys
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.